Status:
COMPLETED
Sight and Hearing Investigation Into Effects on Delirium
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Hearing Loss
Hearing Loss, Age-Related
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The goal of this observational study is to learn about sensory loss in hospital patients with delirium. The main questions it aims to answer are: * Are hearing and vision loss related to increased ri...
Detailed Description
This is a prospective cohort study entitled Sight \& Hearing Investigation into Effects on Delirium (SHIELD), which aims of to characterize the impact of sensory impairment (i.e., vision and/or hearin...
Eligibility Criteria
Inclusion
- inpatient on Johns Hopkins Bayview Medicine A, Medicine B, or Carol Ball unit
- communicates using speech and language
- able to converse in English
Exclusion
- nonverbal
- unable to communicate using English language
- currently under airborne or droplet isolation precautions
Key Trial Info
Start Date :
January 11 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2023
Estimated Enrollment :
1543 Patients enrolled
Trial Details
Trial ID
NCT06176625
Start Date
January 11 2023
End Date
December 15 2023
Last Update
September 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, United States, 21224